Biologics as a therapeutic approach for a Th17-mediated severe dermatitis in skin barrier disorders


Por: Riggioni C, Alvaro-Lozano M and Alsina L

Publicada: 1 nov 2020 Ahead of Print: 1 ago 2020
Resumen:


Filiaciones:
:
 Institut de Recerca Sant Joan de Déu, Barcelona, Spain

 Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain

Alvaro-Lozano M:
 Institut de Recerca Sant Joan de Déu, Barcelona, Spain

 Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain

Alsina L:
 Universitat de Barcelona, Barcelona, Spain

 Institut de Recerca Sant Joan de Déu, Barcelona, Spain

 Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu, Barcelona, Spain

 Clinical Immunology and Primary Immunodeficiencies Unit, Pediatric Allergy and Clinical Immunology Department, Hospital Sant Joan de Déu Barcelona Spain, Barcelona, Spain
ISSN: 01054538





ALLERGY
Editorial
WILEY, 111 RIVER ST, HOBOKEN 07030-5774, NJ, Reino Unido
Tipo de documento: Editorial Material
Volumen: 75 Número: 11
Páginas: 3007-3008
WOS Id: 000561968100001
ID de PubMed: 32583554

MÉTRICAS